Nitin Chitranshi

Dr

  • Source: Scopus
  • Calculated based on no. of publications stored in Pure and citations from Scopus
20062020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Dr Nitin Chitranshi has bachelor and master's degree in Pharmaceutical Sciences. He obtained his doctoral degree in Clinical Medicine and has more than 8 years of teaching and research experience. Dr Chitranshi has also been the research intern at Swiss Institute of Bioinformatics, University of Geneva, Switzerland. He has more than 20 publications and presented in >30 national and international conferences. Dr Chitranshi was a visiting Scientist at Cambridge University, University of Miami and University de Murcia. Currently, his lab efforts are directed in the following key areas: 

  • Neuroserpin-Plasmin interaction in the retina
  • Neurotrophin factor (BDNF, NT3/4/5) signalling in the retina.
  • Viral vector gene delivery and gene manipulation in Rat models and GMO mice.
  • Study signalling proteins affecting retinal cell survival in pathological conditions (Glaucoma, Alzheimer's, and Hypertension).
  • Structural and functional changes in retina involving pERG, pSTR and OCT in rodent’s model.
  • Neuroprotective molecules studies in RGCs damage.
  • High IOP rodent models to study molecular effects on the retina.
  • Membrane protein biology with emphasis on post-translational modifications of the caveolar proteins in glaucoma.
  • Rodents model of optic neuritis with optic nerve micro-injection.
  • Electrode implantation for VEPs recoding in rodents
  • Immunocytochemistry, Immunoblotting, cell culture and handling GMO's.

 

Fingerprint

Dive into the research topics where Nitin Chitranshi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 8 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.
If you made any changes in Pure these will be visible here soon.